CureVac B.V.(CVAC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CVAC CureVac B.V.

未开盘 07-10 16:00:00 EDT

5.45

-0.05

-0.91%

盘后5.45

+0.00+0.00%

18:25 EDT

最高5.49	最低5.43	成交量81.80万
今开5.44	昨收5.50	日振幅1.00%
总市值12.27亿	流通市值6.86亿	总股本2.25亿
成交额446.45万	换手率0.65%	流通股本1.26亿
市净率1.62	ROE33.04%	每股收益0.87
52周最高5.72	52周最低2.37	市盈率6.29
股息0.00	股息收益率0.00	ROA19.93%

北京优虎网络科技有限公司

{"stockData":{"symbol":"CVAC","market":"US","secType":"STK","nameCN":"CureVac B.V.","latestPrice":5.45,"timestamp":1752177600000,"preClose":5.5,"halted":0,"volume":817999,"hourTrading":{"tag":"盘后","latestPrice":5.4498,"preClose":5.45,"latestTime":"18:25 EDT","volume":7312,"amount":39849.1098,"timestamp":1752186307969},"delay":0,"floatShares":125869472,"shares":225172749,"eps":0.866404,"marketStatus":"未开盘","change":-0.05,"latestTime":"07-10 16:00:00 EDT","open":5.44,"high":5.485,"low":5.4302,"amount":4464510.116157,"amplitude":0.009964,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.866404,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752220800000},"marketStatusCode":0,"adr":0,"listingDate":1597377600000,"exchange":"NASDAQ","adjPreClose":5.5,"preHourTrading":{"tag":"盘前","latestPrice":5.45,"preClose":5.5,"latestTime":"09:25 EDT","volume":1534,"amount":8349.9537836,"timestamp":1752153932649},"postHourTrading":{"tag":"盘后","latestPrice":5.4498,"preClose":5.45,"latestTime":"18:25 EDT","volume":7312,"amount":39849.1098,"timestamp":1752186307969},"volumeRatio":1.039338,"impliedVol":3.1252,"impliedVolPercentile":0.96},"requestUrl":"/m/hq/s/CVAC","defaultTab":"news","newsList":[{"id":"2550366020","title":"Curevac N.V.7月9日成交额为541.88万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550366020","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550366020?lang=zh_cn&edition=full","pubTime":"2025-07-10 09:45","pubTimestamp":1752111915,"startTime":"0","endTime":"0","summary":"美东时间2025年7月9日，Curevac N.V.成交额为541.88万美元，成交额较昨日增加53.91%，当日成交量为99.42万股。Curevac N.V.于2025年7月9日涨1.48%，报5.5美元，该股过去5个交易日涨1.66%，年初至今涨61.29%，过去60日涨92.31%。CureVac 曾与葛兰素史克合作开发第二代季节性流感和 COVID-19 疫苗以及禽流感疫苗。该公司其他研发管线中的候选产品还包括针对肿瘤的 mRNA 疫苗和涵盖肿瘤、肝脏及眼部疾病的分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710094523a4416618&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710094523a4416618&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GSK","LU1829250122.USD","CVAC","BK4551","BK4007","BK4548","GSK.UK","BK4585","BK4588","BK4532"],"gpt_icon":0},{"id":"2549577567","title":"Curevac N.V.7月7日成交额为478.86万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549577567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549577567?lang=zh_cn&edition=full","pubTime":"2025-07-08 09:43","pubTimestamp":1751938985,"startTime":"0","endTime":"0","summary":"美东时间2025年7月7日，Curevac N.V.成交额为478.86万美元，成交额较昨日增加17.56%，当日成交量为88.36万股。Curevac N.V.于2025年7月7日跌0.73%，报5.41美元，该股过去5个交易日涨0.56%，年初至今涨58.65%，过去60日涨98.9%。CureVac 曾与葛兰素史克合作开发第二代季节性流感和 COVID-19 疫苗以及禽流感疫苗。该公司其他研发管线中的候选产品还包括针对肿瘤的 mRNA 疫苗和涵盖肿瘤、肝脏及眼部疾病的分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708094313a43cda86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708094313a43cda86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4551","BK4532","BK4585","CVAC","BK4548","BK4007","BK4588","GSK","GSK.UK","LU1829250122.USD"],"gpt_icon":0},{"id":"2548332000","title":"Curevac N.V.7月3日成交额为407.32万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548332000","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548332000?lang=zh_cn&edition=full","pubTime":"2025-07-04 09:43","pubTimestamp":1751593435,"startTime":"0","endTime":"0","summary":"美东时间2025年7月3日，Curevac N.V.成交额为407.32万美元，成交额较昨日增加15.16%，当日成交量为75.10万股。Curevac N.V.于2025年7月3日涨0.93%，报5.45美元，该股过去5个交易日涨0.93%，年初至今涨59.82%，过去60日涨105.66%。CureVac 曾与葛兰素史克合作开发第二代季节性流感和 COVID-19 疫苗以及禽流感疫苗。该公司其他研发管线中的候选产品还包括针对肿瘤的 mRNA 疫苗和涵盖肿瘤、肝脏及眼部疾病的分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704094357a4ce5ae1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704094357a4ce5ae1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4551","BK4588","BK4139","BK4585","BK4007","CVAC","BK4532","GSK","LU1829250122.USD","GSK.UK","BK4548"],"gpt_icon":0},{"id":"2548858706","title":"Curevac N.V.7月1日成交额为608.02万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548858706","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548858706?lang=zh_cn&edition=full","pubTime":"2025-07-02 09:42","pubTimestamp":1751420568,"startTime":"0","endTime":"0","summary":"美东时间2025年7月1日，Curevac N.V.成交额为608.02万美元，成交额较昨日增加13.27%，当日成交量为112.38万股。Curevac N.V.于2025年7月1日跌0.37%，报5.41美元，该股过去5个交易日涨0.93%，年初至今涨58.65%，过去60日涨90.49%。CureVac 曾与葛兰素史克合作开发第二代季节性流感和 COVID-19 疫苗以及禽流感疫苗。该公司其他研发管线中的候选产品还包括针对肿瘤的 mRNA 疫苗和涵盖肿瘤、肝脏及眼部疾病的分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702094252a4c9fc80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702094252a4c9fc80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GSK","BK4139","BK4588","BK4585","GSK.UK","BK4007","CVAC","BK4548","BK4551","LU1829250122.USD","BK4532"],"gpt_icon":0},{"id":"2546773327","title":"Curevac N.V.6月27日成交额为414.03万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546773327","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546773327?lang=zh_cn&edition=full","pubTime":"2025-06-28 09:43","pubTimestamp":1751075001,"startTime":"0","endTime":"0","summary":"美东时间2025年6月27日，Curevac N.V.成交额为414.03万美元，成交额较昨日减少4.82%，当日成交量为77.07万股。Curevac N.V.于2025年6月27日跌0.37%，报5.38美元，该股过去5个交易日跌1.1%，年初至今涨57.77%，过去60日涨97.79%。CureVac 曾与葛兰素史克合作开发第二代季节性流感和 COVID-19 疫苗以及禽流感疫苗。该公司其他研发管线中的候选产品还包括针对肿瘤的 mRNA 疫苗和涵盖肿瘤、肝脏及眼部疾病的分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628094330a4c238ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628094330a4c238ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","GSK.UK","LU1829250122.USD","CVAC","BK4007","BK4551","BK4585","BK4139","GSK","BK4588","BK4548"],"gpt_icon":0},{"id":"2546473772","title":"瑞银：下调CureVac(CVAC.US)评级，由买入调整至中性评级, 目标价由12.00美元调整至5.50美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2546473772","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546473772?lang=zh_cn&edition=full","pubTime":"2025-06-26 23:31","pubTimestamp":1750951889,"startTime":"0","endTime":"0","summary":"瑞银：下调CureVac(CVAC.US)评级，由买入调整至中性评级, 目标价由12.00美元调整至5.50美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/26233151332050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CVAC"],"gpt_icon":0},{"id":"2546873764","title":"瑞银：下调CureVac(CVAC.US)评级，由买入调整至中性评级, 目标价由12.00美元调整至5.50美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2546873764","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546873764?lang=zh_cn&edition=full","pubTime":"2025-06-26 23:26","pubTimestamp":1750951601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CVAC","BK4548","BK4139","BK4551"],"gpt_icon":0},{"id":"2546527538","title":"Curevac N.V.6月25日成交额为600.17万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546527538","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546527538?lang=zh_cn&edition=full","pubTime":"2025-06-26 09:43","pubTimestamp":1750902230,"startTime":"0","endTime":"0","summary":"美东时间2025年6月25日，Curevac N.V.成交额为600.17万美元，成交额较昨日增加83.59%，当日成交量为111.58万股。Curevac N.V.于2025年6月25日涨1.49%，报5.44美元，该股过去5个交易日跌1.09%，年初至今涨59.53%，过去60日涨82.55%。CureVac 曾与葛兰素史克合作开发第二代季节性流感和 COVID-19 疫苗以及禽流感疫苗。该公司其他研发管线中的候选产品还包括针对肿瘤的 mRNA 疫苗和涵盖肿瘤、肝脏及眼部疾病的分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626094355a4be3f19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626094355a4be3f19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","LU1829250122.USD","BK4139","BK4551","BK4588","CVAC","GSK","BK4007","BK4585","BK4532","GSK.UK"],"gpt_icon":0},{"id":"2546268577","title":"Curevac N.V.6月24日成交额为326.91万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546268577","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546268577?lang=zh_cn&edition=full","pubTime":"2025-06-25 09:41","pubTimestamp":1750815705,"startTime":"0","endTime":"0","summary":"美东时间2025年6月24日，Curevac N.V.成交额为326.91万美元，成交额较昨日减少20.62%，当日成交量为60.89万股。Curevac N.V.于2025年6月24日跌0.65%，报5.36美元，该股过去5个交易日跌2.9%，年初至今涨57.18%，过去60日涨91.43%。CureVac 曾与葛兰素史克合作开发第二代季节性流感和 COVID-19 疫苗以及禽流感疫苗。该公司其他研发管线中的候选产品还包括针对肿瘤的 mRNA 疫苗和涵盖肿瘤、肝脏及眼部疾病的分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625094147a4bc61ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625094147a4bc61ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GSK","BK4551","BK4139","LU1829250122.USD","BK4548","BK4588","BK4007","BK4532","BK4585","CVAC","GSK.UK"],"gpt_icon":0},{"id":"2545422101","title":"Curevac N.V.6月23日成交额为411.85万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545422101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545422101?lang=zh_cn&edition=full","pubTime":"2025-06-24 09:41","pubTimestamp":1750729282,"startTime":"0","endTime":"0","summary":"美东时间2025年6月23日，Curevac N.V.成交额为411.85万美元，成交额较昨日减少63.13%，当日成交量为76.39万股。Curevac N.V.于2025年6月23日跌0.83%，报5.4美元，该股过去5个交易日跌3.14%，年初至今涨58.21%，过去60日涨89.3%。CureVac 曾与葛兰素史克合作开发第二代季节性流感和 COVID-19 疫苗以及禽流感疫苗。该公司其他研发管线中的候选产品还包括针对肿瘤的 mRNA 疫苗和涵盖肿瘤、肝脏及眼部疾病的分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624094128a4ba82d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624094128a4ba82d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","BK4551","BK4548","LU1829250122.USD","CVAC","BK4588","GSK","BK4585","BK4007","GSK.UK","BK4139"],"gpt_icon":0},{"id":"2545109043","title":"Curevac N.V.6月20日成交额为1117.08万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545109043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545109043?lang=zh_cn&edition=full","pubTime":"2025-06-21 09:42","pubTimestamp":1750470124,"startTime":"0","endTime":"0","summary":"美东时间2025年6月20日，Curevac N.V.成交额为1117.08万美元，成交额较昨日增加101.50%，当日成交量为204.39万股。Curevac N.V.于2025年6月20日跌0.91%，报5.44美元，该股过去5个交易日跌2.86%，年初至今涨59.53%，过去60日涨86.94%。CureVac 曾与葛兰素史克合作开发第二代季节性流感和 COVID-19 疫苗以及禽流感疫苗。该公司其他研发管线中的候选产品还包括针对肿瘤的 mRNA 疫苗和涵盖肿瘤、肝脏及眼部疾病的分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621094205a4b58e02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621094205a4b58e02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GSK","BK4139","BK4588","BK4585","GSK.UK","BK4007","CVAC","BK4548","BK4551","LU1829250122.USD","BK4532"],"gpt_icon":0},{"id":"2543514096","title":"Curevac N.V.6月13日成交额为2674.78万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543514096","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543514096?lang=zh_cn&edition=full","pubTime":"2025-06-14 09:42","pubTimestamp":1749865355,"startTime":"0","endTime":"0","summary":"美东时间2025年6月13日，Curevac N.V.成交额为2674.78万美元，成交额较昨日减少78.92%，当日成交量为483.49万股。Curevac N.V.于2025年6月13日跌0.54%，报5.57美元，该股过去5个交易日涨26.3%，年初至今涨63.34%，过去60日涨83.22%。该公司成立于2000年，并于2020年8月进行了首次公开募股。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614094237a7089015&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614094237a7089015&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4548","CVAC","BK4551"],"gpt_icon":0},{"id":"1114205489","title":"美股异动 | 生物科技公司CureVac涨幅扩大至37%，获BioNTech以12.5亿美元收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1114205489","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114205489?lang=zh_cn&edition=full","pubTime":"2025-06-12 22:24","pubTimestamp":1749738265,"startTime":"0","endTime":"0","summary":"BioNTech将以12.5亿美元收购CureVac。","market":"us","thumbnail":"https://static.tigerbbs.com/a73bfb76c91f80045aa7a80f79e0786b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a73bfb76c91f80045aa7a80f79e0786b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4868bc7389eb9be96f392fda68b1dfce","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVAC"],"gpt_icon":0},{"id":"2542517366","title":"Curevac N.V.盘中异动 早盘股价大涨32.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542517366","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542517366?lang=zh_cn&edition=full","pubTime":"2025-06-12 21:32","pubTimestamp":1749735167,"startTime":"0","endTime":"0","summary":"北京时间2025年06月12日21时32分，Curevac N.V.股票出现波动，股价急速拉升32.92%。截至发稿，该股报5.41美元/股，成交量791.495万股，换手率3.52%，振幅3.19%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为0.23%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612213247a7056878&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"3027c44315e197be94df144e6d65b09b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612213247a7056878&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4139","CVAC","BK4551"],"gpt_icon":0},{"id":"1198330535","title":"异动解读 | CureVac盘前大涨28.99%，BioNTech拟12.5亿美元收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1198330535","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198330535?lang=zh_cn&edition=full","pubTime":"2025-06-12 19:06","pubTimestamp":1749726397,"startTime":"0","endTime":"0","summary":"生物科技公司CureVac B.V.今日盘前大涨28.99%，引发市场高度关注。根据最新消息，德国生物科技巨头BioNTech计划以12.5亿美元收购CureVac，此举旨在增强BioNTech的癌症业务。这一收购消息成为推动CureVac股价大幅上涨的主要原因。此次收购对双方都具有重要意义。对BioNTech而言，收购CureVac将有助于其扩大在癌症治疗领域的布局，进一步增强其在生物科技行业的竞争力。对CureVac来说，被行业巨头收购不仅能为公司带来可观的溢价，还可能为其研发项目提供更多资源和支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3027c44315e197be94df144e6d65b09b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"异动解读 | CureVac盘前大涨28.99%，BioNTech拟12.5亿美元收购","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CVAC"],"gpt_icon":0},{"id":"2542341933","title":"Curevac N.V.盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542341933","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542341933?lang=zh_cn&edition=full","pubTime":"2025-06-11 00:46","pubTimestamp":1749573985,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日00时46分，Curevac N.V.股票出现波动，股价大幅下挫5.13%。截至发稿，该股报4.25美元/股，成交量36.7518万股，换手率0.16%，振幅5.58%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为0.73%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611004625a4a239ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611004625a4a239ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CVAC","BK4551","BK4548"],"gpt_icon":0},{"id":"2541409824","title":"Curevac N.V.盘中异动 下午盘股价大跌5.01%报4.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541409824","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541409824?lang=zh_cn&edition=full","pubTime":"2025-06-05 01:23","pubTimestamp":1749057782,"startTime":"0","endTime":"0","summary":"北京时间2025年06月05日01时23分，Curevac N.V.股票出现波动，股价急速下挫5.01%。截至发稿，该股报4.46美元/股，成交量41.6556万股，换手率0.19%，振幅4.50%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为0.40%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605012303a49a3012&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605012303a49a3012&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","CVAC","BK4139","BK4551"],"gpt_icon":0},{"id":"2540479544","title":"Curevac N.V.盘中异动 早盘股价大涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540479544","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540479544?lang=zh_cn&edition=full","pubTime":"2025-06-02 21:31","pubTimestamp":1748871100,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日21时31分，Curevac N.V.股票出现波动，股价大幅上涨5.15%。截至发稿，该股报4.70美元/股，成交量5.0607万股，换手率0.02%，振幅0.40%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为0.26%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213140976e808d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213140976e808d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4551","BK4548","BK4139","CVAC"],"gpt_icon":0},{"id":"2538046243","title":"Curevac N.V.盘中异动 早盘股价大涨5.13%报4.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538046243","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538046243?lang=zh_cn&edition=full","pubTime":"2025-05-27 22:04","pubTimestamp":1748354652,"startTime":"0","endTime":"0","summary":"北京时间2025年05月27日22时04分，Curevac N.V.股票出现波动，股价大幅上涨5.13%。截至发稿，该股报4.30美元/股，成交量12.8442万股，换手率0.06%，振幅4.40%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为1.06%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527220412a48e7c07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527220412a48e7c07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4548","BK4551","CVAC"],"gpt_icon":0},{"id":"2537926057","title":"Curevac N.V.盘中异动 下午盘股价大涨5.00%报4.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537926057","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537926057?lang=zh_cn&edition=full","pubTime":"2025-05-23 01:40","pubTimestamp":1747935610,"startTime":"0","endTime":"0","summary":"北京时间2025年05月23日01时40分，Curevac N.V.股票出现波动，股价急速拉升5.00%。截至发稿，该股报4.10美元/股，成交量41.0328万股，换手率0.18%，振幅5.90%。Curevac N.V.股票所在的生物技术行业中，整体跌幅为0.46%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523014010a4888b7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523014010a4888b7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4551","CVAC","BK4139","BK4548"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.curevac.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.2763},{"period":"3month","weight":0.7085},{"period":"6month","weight":0.2945},{"period":"1year","weight":0.7524},{"period":"ytd","weight":0.5982}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":0.0377},{"period":"3month","weight":0.1721},{"period":"6month","weight":0.0781},{"period":"1year","weight":0.1149},{"period":"ytd","weight":0.0678}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Curevac N.V.于2020年4月7日根据荷兰法律注册成立。该公司是一家全球性的临床阶段生物制药公司，开发基于信使核糖核酸的新型转化药物，该药物具有改善人们生活的潜力。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.081893},{"month":2,"riseRate":0.2,"avgChangeRate":-0.099557},{"month":3,"riseRate":0.2,"avgChangeRate":-0.055603},{"month":4,"riseRate":0.6,"avgChangeRate":0.064149},{"month":5,"riseRate":0.8,"avgChangeRate":0.233107},{"month":6,"riseRate":0.4,"avgChangeRate":-0.089668},{"month":7,"riseRate":0.4,"avgChangeRate":-0.074267},{"month":8,"riseRate":0.25,"avgChangeRate":-0.027881},{"month":9,"riseRate":0,"avgChangeRate":-0.164639},{"month":10,"riseRate":0.2,"avgChangeRate":-0.117332},{"month":11,"riseRate":0.8,"avgChangeRate":0.284319},{"month":12,"riseRate":0.2,"avgChangeRate":-0.143623}],"exchange":"NASDAQ","name":"CureVac B.V.","nameEN":"CureVac B.V."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CureVac B.V.(CVAC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CureVac B.V.(CVAC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CureVac B.V.,CVAC,CureVac B.V.股票,CureVac B.V.股票老虎,CureVac B.V.股票老虎国际,CureVac B.V.行情,CureVac B.V.股票行情,CureVac B.V.股价,CureVac B.V.股市,CureVac B.V.股票价格,CureVac B.V.股票交易,CureVac B.V.股票购买,CureVac B.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CureVac B.V.(CVAC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CureVac B.V.(CVAC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}